Risk factors for impaired<scp>CD</scp>4<sup>+</sup>T‐cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation
Hélène Longuet(Centre Hospitalier Universitaire de Tours), Matthias Büchler(Centre Hospitalier Universitaire de Tours), Yvon Lebranchu(Académie Nationale de Médecine), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Gilles Thibault, Philippe Gatault(Centre Hospitalier Universitaire de Tours), Christelle Barbet(Centre Hospitalier Régional Universitaire de Brest), Christophe Baron(Université de Tours), Bénédicte Sautenet(Université de Tours)
Cited by 28
Related Papers
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
|Kidney International|2018|206
Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) Consensus Workshop
|American Journal of Kidney Diseases|2020|201
Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population
|Kidney International|2000|191